Our objective was a retrospective assessment of the management modalities that provided the most beneficial treatment in hemorrhagic moyamoya disease during the last 13 years at our institution. The clinical results of 44 patients with hemorrhagic moyamoya disease were investigated, comparing revascularization surgery (direct, indirect, and combined bypass) or conservative treatment. Angiographic features, rebleeding, and clinical outcome were investigated. Six of the 35 patients (17.1%) with revascularization surgery experienced rebleeding, as did 4 of 9 patients (44.4%) with conservative treatment. However, patients who underwent bypass surgery had a lower chance of rebleeding. No significant difference in chance of rebleeding was observed between bypass surgery and non surgery groups (p > 0.05). Cerebral angiography performed after bypass surgery showed that for achieving good postoperative revascularization, direct and combined bypass methods were much more effective (p < 0.05). While the risk of rebleeding in the revascularization group was generally lower than in the conservative treatment group, there was no statistically significant difference between treatment modalities and conservative treatment. Although statistical significance was not attained, direct and combined bypass may reduce the risk of hemorrhage more effectively than indirect bypass.
INTRODUCTION
Moyamoya disease (MMD) is a rare cerebrovascular disorder characterized by progressive occlusion of the bilateral supraclinoid internal carotid artery (ICA), proximal middle cerebral artery (MCA), and anterior cerebral artery (ACA), and a spontaneously developed collateral vascular network at the base of the brain consisting of the so-called moyamoya vessels.
17)23)24)
Clinically, MMD can be divided into 2 entities: juvenile and adult onset types. Clinical presentation of MMD includes ischemia and hemorrhage in adults, as well as ischemic attacks in children. 4) 16) The goal of revascularization surgery for hemorrhagic MMD is to reduce the hemodynamic stress on the moyamoya vessels, but also acts as secondary preventive measure of stroke in the symptomatic moyamoya vessels ipsilateral to the hemorrhage. 
MATERIALS AND METHODS
From 1998 to 2010, we diagnosed 44 patients with adult MMD (over 17 years of age) with hemorrhagic attack treated at our institution. In this series, data from these patients' records were retrospectively good, moderate, and poor. If the decrease in the number of moyamoya vessels after revascularization exceeded one third of those counted preoperatively, the change was classified as "good". If the number of moyamoya vessels decreased was less than one third of those counted preoperatively, the change was determined to be "moderate". If these criteria were not met or no changes were observed, the angiographic change was determined to be "poor". For ease of statistical analysis, the angiographic changes were converted into a numerical score in which good is equal to 3, moderate is equal to 2, and poor is equal to 1.
The follow-up period was 12 to 105 months (mean of 55.4 months). We confirmed recurrent intracranial hemorrhage and ischemic events using CT and MRI 
RESULTS

General demographic data
Among the 44 adult hemorrhagic MMD patients, bypass surgery was performed in 35 patients (79.5%) with 53 sides (17 patients unilaterally, 18 patients bilaterally) and conservative treatment in 9 patients (20.4%). All patients had intracranial hemorrhage.
Basal cerebral blood flow (CBF) decreased in reaction to acetazolamide challenge in all cases. Revascularization surgery was performed more than a month after first hemorrhagic attack. Among the 35 surgically treated patients, 9 patients (25.7%) underwent direct bypass, 18 patients (51.4%) underwent indirect bypass, and 8 patients (22.9%) underwent combined bypass. Table 1 shows the demographic characteristics of the patients. (Table 3 ). According to Kaplan-Meier plots of stroke free time, patients with revascularization surgery remained stroke free longer than conservatively treated patients. The mean stroke free times of patients in the direct bypass group were 70.3 ± 7.5 months, 77.4 ± 5.8 months in the indirect bypass group, 81.1 ± 9.6 months in the combined bypass group, and 41.8 ± 3.7 months in the conservative treatment group. There was no statistical difference (p = 0.09) between revascularization and conservative treatment groups (Fig. 1) .
Final clinical status
Clinical status at the end of the study was assessed using the RDS. 21) Among 35 patients who underwent revascularization surgery, 22 patients (62.9%) had improvement of the RDS scores at last follow-up.
According to the bypass methods, the RDS score for the 9 patients with direct bypass improved from 3. (Table 4 ). More significant decrease of moyamoya vessels and increase of neovascularization were observed in direct/combined bypass groups compared to indirect groups (p < 0.05).
DISCUSSION
Moyamoya disease is a progressive, occlusive disease of the cerebral vasculature with particular involvement of the circle of Willis that affects more those of young age.
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The clinical symptoms of MMD relate directly to abnormal vasculature, known as Moyamoya vessels. 5) In children it tends to cause recurrent cerebral ischemic attacks or seizures. In adults it tends to cause intracranial hemorrhage. 17) The prevalence of hemorrhage is reported to be greater than 60% in adults, much higher than the 10% seen in children. 6) The reason for higher prevalence in adults is not known. However, the difference may be a result of the stability of systemic hemodynamics between adult and pediatric patients, as flexibility of moyamoya vessels might be higher in children. 17) In hemorrhagic MMD, whether bypass surgery would prevent recurrent hemorrhagic attack is an important debate, as recurrent hemorrhagic attacks interfere with a good long-term prognosis.
According to Kobayashi et al., in hemorrhagic moyamoya patients recurrent hemorrhagic attack long after the initial hemorrhage is not uncommon. 14) After rebleeding, the chance of good recovery dropped from 45.5% to 21.4%, and the mortality rate increased from 
CONCLUSION
From the results of our study, although there is still no clear evidence that revascularization surgery completely excludes chance of rebleeding in patients with hemorrhagic MMD, a preventive effect is expected.
We statistically confirmed that both direct and combined bypass were much more effective for achieving a good extent of revascularization and decrease of moyamoya vessels than indirect bypass. To sum up these results, we cautiously recommend direct and combined bypass as a choice of treatment in hemorrhagic MMD over indirect bypass. A long-term, large, prospective, randomized clinical trial is needed to clarify which surgical method is best in patients with hemorrhagic MMD.
